Drugs / INCB 99280
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05909995 | Aug 2023 → Sep 2024 | colorectal carcinoma, hepatocellular carcinoma, melanoma, renal cell carcinoma | Incyte Corporation | Terminated | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INCB 99280 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05909995 ↗ |